6-(N-ethyl-N-(5-isobutoxy-4-isopropyl-2-(E)-styrylphenyl)amino)nicotinic acid

From WikiMD's Wellness Encyclopedia


6-(N-ethyl-N-(5-isobutoxy-4-isopropyl-2-(E)-styrylphenyl)amino)nicotinic acid is a synthetic organic compound that has been studied for its potential pharmacological properties. This compound is of interest in the field of medicinal chemistry due to its structural features and potential biological activity.

Chemical Structure and Properties[edit | edit source]

The chemical structure of 6-(N-ethyl-N-(5-isobutoxy-4-isopropyl-2-(E)-styrylphenyl)amino)nicotinic acid consists of a nicotinic acid moiety linked to a substituted styrylphenyl group through an ethylamino linkage. The presence of the isobutoxy and isopropyl groups, along with the styryl moiety, contributes to the compound's lipophilicity and potential interaction with biological targets.

IUPAC Name[edit | edit source]

The IUPAC name for this compound is 6-(N-ethyl-N-(5-isobutoxy-4-isopropyl-2-(E)-styrylphenyl)amino)pyridine-3-carboxylic acid.

Molecular Formula[edit | edit source]

The molecular formula of this compound is C28H33NO3.

Molecular Weight[edit | edit source]

The molecular weight is approximately 431.57 g/mol.

Synthesis[edit | edit source]

The synthesis of 6-(N-ethyl-N-(5-isobutoxy-4-isopropyl-2-(E)-styrylphenyl)amino)nicotinic acid involves multiple steps, typically starting from commercially available precursors. The key steps include the formation of the styrylphenyl moiety, followed by the introduction of the ethylamino linkage and the nicotinic acid group.

Pharmacological Activity[edit | edit source]

Research into the pharmacological activity of this compound is ongoing. It is hypothesized that the compound may interact with certain receptors or enzymes in the body, potentially leading to therapeutic effects. However, detailed studies are required to elucidate its mechanism of action and potential applications.

Potential Applications[edit | edit source]

Due to its structural similarity to other bioactive compounds, 6-(N-ethyl-N-(5-isobutoxy-4-isopropyl-2-(E)-styrylphenyl)amino)nicotinic acid may have potential applications in the development of new pharmaceuticals. It could be explored for its effects on inflammation, cancer, or neurological disorders.

Safety and Toxicology[edit | edit source]

As with any novel compound, the safety and toxicological profile of 6-(N-ethyl-N-(5-isobutoxy-4-isopropyl-2-(E)-styrylphenyl)amino)nicotinic acid must be thoroughly evaluated. Preclinical studies involving in vitro and in vivo models are necessary to assess its safety for potential therapeutic use.

Also see[edit | edit source]




WikiMD
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD